Mario Riesner

Novartis Opens Production Facility for Innovative Eye Retina Product in Tyrol

The pharmaceutical company Novartis is investing EUR 27.4 million in the Kundl site in Tyrol to produce an active ingredient for a new therapy for wet age-related macular degeneration with 40 employees.

June 20, 2020
Fast News Search